About Jiuyou Capital
Jiuyou Capital is a private equity firm founded in 2015. It is primarily based in China.
Overall Jiuyou Capital portfolio has seen 7 IPOs, namely BeiGene, UBTECH and Cambricon. A lot of funds co-invest with Jiuyou Capital, with names like Chinese Academy of Sciences sharing a substantial percentage of its portfolio.
Jiuyou Capital has a team of 2 people, including 2 partners.
Jiuyou Capital's Portfolio
They have invested in a total of 29 companies. Their most recent investment was in Guangzhou Maijing Gene Medical Technology (Series C round) on Dec 29, 2022. Here is the most recent investment by Jiuyou Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Dec 29, 2022 | Series C | 3233 | ||
Mar 18, 2022 | Series A | 5746 | ||
Aug 11, 2021 | Series A | 1644 | ||
Aug 09, 2021 | Series A | 3668 |
Here is the portfolio snapshot of Jiuyou Capital:
Investments by Year
The maximum number of investments were made in 2019
Team profile of Jiuyou Capital
Jiuyou Capital has a team of 2 members including 2 Partners. Jiuyou Capital's team does not sit on the board of any company as of now.Co-investors of Jiuyou Capital
Over the past 11 years, 37 investors have co-invested in Jiuyou Capital's portfolio companies.
- Top Co-investors of Jiuyou Capital: 37 investors entered a company along with Jiuyou Capital. These include investors like Chinese Academy of Sciences (2 companies).
Jiuyou Capital News
•
•
•
"Yuxi Medicine" received tens of millions of yuan in Pre-A round of financing36Kr•Jan 23, 2022•Mingfeng Capital, Jiuyou Capital, 3E Bioventures Capital
•
"Jinda" announced the completion of Series B financing, led by Tigermed and Baidu Ventures36Kr•Nov 14, 2021•Jisi Yingda Pharmaceutical Technology, Baidu, Jiuyou Capital, Efung Capital and 3 others
•
•
Tianbing Technology Receives Hundreds of Million Yuan Pre-B Round Strategic Financing to Help the First Liquid Rocket Flight TestPEdaily•Jul 27, 2021•CAS Investment Management, Eagles Fund, Landstone Capital, Jiuyou Capital and 1 other
•
•
SinoVision completed the pre-IPO round of financing of hundreds of millions of yuan, Haisong Capital led the investmentPEdaily•Dec 31, 2020•Sinovent, CDIB Capital Group, Jiuyou Capital, Oceanpine Capital
•
Innovative antibody drug company Wei Dejie Biotechnology obtains Series B financingPEdaily•Nov 30, 2020•SDIC Venture Capital Management, Jiuyou Capital
•
Chinese biopharma startup Sinovent closes $145m Series C roundDeal Street Asia•Aug 25, 2020•Sinovent, Jiuyou Capital, CICC Capital, CICC and 3 others
